| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | Doxorubicin | CTRPv2 | pan-cancer | AAC | -0.08 | 0.007 |
| mRNA | paclitaxel | gCSI | pan-cancer | AAC | -0.14 | 0.007 |
| mRNA | ML050 | CTRPv2 | pan-cancer | AAC | 0.096 | 0.009 |
| mRNA | Talazoparib | GDSC1000 | pan-cancer | AAC | -0.087 | 0.01 |
| mRNA | Cerulenin | CTRPv2 | pan-cancer | AAC | 0.085 | 0.01 |
| mRNA | BRD-K71781559 | CTRPv2 | pan-cancer | AAC | 0.099 | 0.01 |
| mRNA | Crizotinib | gCSI | pan-cancer | AAC | -0.15 | 0.01 |
| mRNA | PD-0332991 | CCLE | pan-cancer | AAC | -0.12 | 0.01 |
| mRNA | EHT 1864 | GDSC1000 | pan-cancer | AAC | 0.085 | 0.01 |
| mRNA | Lisitinib | GDSC1000 | pan-cancer | AAC | -0.084 | 0.01 |